XML 39 R15.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Derivative Financial Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2012
Derivative [Line Items] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] | The following table summarizes the Company's activity and fair value calculations of its derivative warrants and convertible promissory notes for the nine months ended September 30, 2012.
| Linked Common Shares to Derivative Warrants | Warrant Liability | Linked Common Shares to Promissory Notes | Compound Embedded Derivatives
Beginning balance, December 31, 2011 | 154,132 |  | $ | 752,486 |  | — |  | $ | — |
Issuance of promissory note with compound embedded derivative - February 3, 2012 | — |  | — |  | 23,416 |  | 12,151 |
Issuance of $75,000 promissory note with compound embedded derivative - June 6, 2012 | — |  | — |  | 26,042 |  | 15,625 |
Issuance of warrants to underwriters - September 11, 2012 | 110,000 |  | 49,170 |  | — |  | — |
Exchange of warrants for common stock | (135,782 | ) | (19,823 | ) | — |  | — |
Change in fair value of derivatives | — |  | (738,628 | ) | 623,279 |  | 56,989 |
Ending balance, September 30, 2012 | 128,350 |  | $ | 43,205 |  | 672,737 |  | $ | 84,765 |
Schedule of Compound Embedded Derivative [Table Text Block] | The following table shows the summary calculations arriving at the compound embedded derivative values as of February 3, 2012 , June 6, 2012 and September 30, 2012. See the assumption details for the composition of these calculations.
Compound Embedded Derivative | February 3, 2012 |  | June 6, 2012 |  | September 30, 2012
Notional amount | $ | 505,785 |  |  | $ | 75,000 |  |  | $ | 532,808 |
Conversion price | 21.60 |  |  | 2.88 |  |  | 0.79 |
Linked common shares (1) | 23,416 |  |  | 26,042 |  |  | 672,737 |
MCS value per linked common share (2) | 0.52 |  |  | 0.60 |  |  | 0.13 |
Total | $ | 12,151 |  |  | $ | 15,625 |  |  | $ | 84,765 |
(1) The Compound Embedded Derivative is linked to a variable number of common shares based upon a percentage of the Company's closing stock price as reflected in the over-the-counter market. The number of linked shares will increase as the trading market price decreases and will decrease as the trading market price increases. The fluctuation in the number of linked common shares will have an effect on fair values in future periods. (2) The Note embodied a contingent conversion feature that was predicated upon a financing transaction that was planned for a date between the issuance date and March 2, 2012. If the financing occurred, the maturity date of the Note was August 2, 2012. If the financing did not occur, the maturity date of the Note was February 2, 2013. While, in hindsight, the financing did not occur, the calculation of value must consider that on the issuance date the contingency was present and resulted in multiple scenarios of outcome as it related to the conversion feature subject to bifurcation. The mechanism for building this contingency into the MCS value was to perform two separate calculations of value and weight them on a reasonable basis.
Binomial Lattice Option Valuation Technique [Member] |
Derivative [Line Items] |
Schedule of Price Risk Derivatives [Table Text Block] | The derivative warrants were valued using a Binomial Lattice Option Valuation Technique (“Binomial”). Significant inputs into this technique on September 30, 2012 and 2011 are as follows:
Binomial Assumptions | September 30, 2012 |  | September 30, 2011
Fair market value of asset (1) | $0.88 |  | $13.20
Exercise price | $20.00 |  | $20.00
Term (2) | 3.6 years |  | 4.6--4.9 Years
Implied expected life (3) | 3.6 years |  | 4.5--4.8 Years
Volatility range of inputs (4) | 49.6%--70.5% |  | 62.2%--93.6%
Equivalent volatility (3) | 58.30% |  | 75.2%
Risk-free interest rate range of inputs (5) | 0.10%--0.31% |  | 0.02%--0.96%
Equivalent risk-free interest rate (3) | 0.19% |  | 0.28%--0.33%
(1) The fair market value of the asset was determined by the Company using all available information including, but not limited to the trading market price and the actual, negotiated prices paid by the independent investors in the May 2011 Offering and a private offering in December 2011. (2) The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate. (3) The implied expected life, and equivalent volatility and risk-free interest rate amounts are derived from the Binomial. (4) The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (1), above. (5) The risk-free rates used for inputs represent the yields on zero coupon US Government Securities with periods to maturity consistent with the intervals described in (1), above.
Monte Carlo Simulation Technique [Member] |
Derivative [Line Items] |
Schedule of Price Risk Derivatives [Table Text Block] | Significant inputs into the Monte Carlo Simulation used to calculate the compound embedded derivative values as of February 3, 2012, June 6, 2012 and September 30, 2012 are as follows:
| Inception Date |  | Inception Date |  |
Monte Carlo Assumptions | February 3, 2012 |  | June 6, 2012 |  | September 30, 2012
Fair market value of asset (1) | $12.50 |  | $3.20 |  | $0.88
Conversion price | $21.60 |  | $2.88 |  | $0.79
Term (2) | .5 - 1 year |  | 0.60 years |  | 0.34 years
Implied expected life (3) | 0.74 years |  | 0.58 years |  | 0.34 years
Volatility range of inputs (4) | 44.23%--70.30% |  | 53.54%--68.00% |  | 39.91%--49.84%
Equivalent volatility (3) | 55.9% |  | 59.2% |  | 45.4%
Risk adjusted interest rate range of inputs (5) | 10.00%--30.95% |  | 7.62%--12.33% |  | 8.18%--10.00%
Equivalent risk-adjusted interest rate (3) | 16.43% |  | 9.33% |  | 9.19%
Credit risk-adjusted interest rate (6) | 12.71% |  | 15.74% |  | 14.90%
(1) The fair market value of the asset was determined by management using all available information including, but not limited to the trading market price and the actual, negotiated prices paid by a private offering in December 2011. (2) The term is the contractual remaining term, allocated among twelve equal intervals for purposes of calculating other inputs, such as volatility and risk-free rate. (3) The implied expected life, and equivalent volatility and risk-free risk-adjusted interest rate amounts are derived from the MCS. (4) The Company does not have a market trading history upon which to base its forward-looking volatility. Accordingly, the Company selected peer companies that provided a reasonable basis upon which to calculate volatility for each of the intervals described in (1), above. (5) CED's bifurcated from debt instruments are expected to contain an element of market interest risk. That is, the risk that market driven interest rates will change during the term of a fixed rate debt instrument. (6) The Company utilized a yield approach in developing its credit risk assumption. The yield approach assumes that the investor's yield on the instrument embodies a risk component, generally, equal to the difference between the actual yield and the yield for a similar instrument without regard to risk.

X
- Definition Schedule of Compound Embedded Derivative [Table Text Block] + References No definition available. + Details
Name: | izea_ScheduleOfCompoundEmbeddedDerivativeTableTextBlock
Namespace Prefix: | izea_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DerivativeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 205G -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 44C -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of price risk derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfPriceRiskDerivativesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration